Literature DB >> 18469818

Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity.

Jeff Holst1, Haopeng Wang, Kelly Durick Eder, Creg J Workman, Kelli L Boyd, Zachary Baquet, Harvir Singh, Karen Forbes, Andrzej Chruscinski, Richard Smeyne, Nicolai S C van Oers, Paul J Utz, Dario A A Vignali.   

Abstract

The T cell antigen receptor (TCR)-CD3 complex is unique in having ten cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs). The physiological importance of this high TCR ITAM number is unclear. Here we generated 25 groups of mice expressing various combinations of wild-type and mutant ITAMs in TCR-CD3 complexes. Mice with fewer than seven wild-type CD3 ITAMs developed a lethal, multiorgan autoimmune disease caused by a breakdown in central rather than peripheral tolerance. Although there was a linear correlation between the number of wild-type CD3 ITAMs and T cell proliferation, cytokine production was unaffected by ITAM number. Thus, high ITAM number provides scalable signaling that can modulate proliferation yet ensure effective negative selection and prevention of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469818     DOI: 10.1038/ni.1611

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  71 in total

1.  Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery.

Authors:  Shaobo Han; Ayuna Asoyan; Hannah Rabenstein; Naoko Nakano; Reinhard Obst
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

Review 2.  New tools for classification and monitoring of autoimmune diseases.

Authors:  Holden T Maecker; Tamsin M Lindstrom; William H Robinson; Paul J Utz; Matthew Hale; Scott D Boyd; Shai S Shen-Orr; C Garrison Fathman
Journal:  Nat Rev Rheumatol       Date:  2012-05-31       Impact factor: 20.543

3.  Functional evidence for TCR-intrinsic specificity for MHCII.

Authors:  Heather L Parrish; Neha R Deshpande; Jelena Vasic; Michael S Kuhns
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

4.  Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.

Authors:  Maike Jaworski; Ben J Marsland; Jasmine Gehrig; Werner Held; Stéphanie Favre; Sanjiv A Luther; Mai Perroud; Déla Golshayan; Olivier Gaide; Margot Thome
Journal:  EMBO J       Date:  2014-10-15       Impact factor: 11.598

Review 5.  Integration of cytokine and heterologous receptor signaling pathways.

Authors:  Jelena S Bezbradica; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

Review 6.  Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice.

Authors:  Alfred Singer; Stanley Adoro; Jung-Hyun Park
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

7.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

8.  Evidence for a functional sidedness to the alphabetaTCR.

Authors:  Michael S Kuhns; Andrew T Girvin; Lawrence O Klein; Rebecca Chen; Kirk D C Jensen; Evan W Newell; Johannes B Huppa; Björn F Lillemeier; Morgan Huse; Yueh-Hsiu Chien; K Christopher Garcia; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-02       Impact factor: 11.205

9.  Functional role of T-cell receptor nanoclusters in signal initiation and antigen discrimination.

Authors:  Sophie V Pageon; Thibault Tabarin; Yui Yamamoto; Yuanqing Ma; Philip R Nicovich; John S Bridgeman; André Cohnen; Carola Benzing; Yijun Gao; Michael D Crowther; Katie Tungatt; Garry Dolton; Andrew K Sewell; David A Price; Oreste Acuto; Robert G Parton; J Justin Gooding; Jérémie Rossy; Jamie Rossjohn; Katharina Gaus
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-29       Impact factor: 11.205

Review 10.  Organization of proximal signal initiation at the TCR:CD3 complex.

Authors:  Clifford S Guy; Dario A A Vignali
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.